Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why Traders Are Clamoring Over These 5 Stocks Today

Page 1 of 2

It’s a good day to be a bull on Wall Street as all three indexes and crude futures are in the green. Today’s ADP jobs report came in ahead of expectations and traders are optimistic on the EIA report scheduled to be released later today.

Among the stocks trending this morning are Second Sight Medical Products Inc (NASDAQ:EYES), Citigroup Inc (NYSE:C), Bank of America Corp (NYSE:BAC), Whiting Petroleum Corp (NYSE:WLL), and Seadrill Ltd (NYSE:SDRL). Let’s take a closer look at why these equities are in the spotlight and see how elite funds are positioned in them.

Hedge funds and other institutional investors allocate significant resources while making their bets and their long-term focus makes them the perfect investors to emulate. This is supported by our research, which determined that following the small-cap stocks that hedge funds are collectively bullish on can help a smaller investor to beat the S&P 500 by around 95 basis points per month (see the details here).

oil, rig, gas, drilling, drill, platform, petroleum, petrol, sea, spill, background, plant, fuel, coast, ocean, gulf, liquid, black, fossil, environmental, derrick, abstract, sky, water,


Second Sight Surge on Proposed CMS Reimbursement Rate

Second Sight Medical Products Inc (NASDAQ:EYES) is 24% higher today after the Centers for Medicare & Medicaid Services posted the proposed rules for the 2017 Medicare Hospital Outpatient Prospective Payment System. The new proposed rules include a potential outpatient rate of approximately $150,000 for Argus II and the associated surgical implantation procedure for calendar year 2017. That’s 59% higher than 2016’s rate of $95,000, which bodes extremely well for Second Sight. Four elite funds had a bullish long position in Second Sight Medical Products Inc (NASDAQ:EYES) at the end of March, down by one from the beginning of the quarter.

Follow Second Sight Medical Products Inc (NASDAQ:EYES)
Trade (NASDAQ:EYES) Now!

Citigroup to Combine EMEA and Asian Consumer Segments

Citigroup Inc (NYSE:C) is in the spotlight after Reuters reported that the bank is combining its consumer banking segment in Asia with its consumer business in Europe, the Middle East, and Africa (EMEA). The combination should simplify Citigroup’s sprawling emerging market presence and boost its efficiency. Shares of the bank have fallen by 20% year-to-date and trade for just 0.58-times book value due to concerns of an emerging market recession and continued low interest rates. Of the 766 elite funds that we track, 101 of them owned $8.04 billion worth of Citigroup Inc (NYSE:C) shares on March 31, which accounted for 6.50% of the float.

Follow Citigroup Inc (NYSE:C)
Trade (NYSE:C) Now!

On the next page we examine the latest concerning Bank of America, Whiting Petroleum, and Seadrill.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!